ArticleCell death & disease2012

Targeting of distinct signaling cascades and cancer-associated fibroblasts define the efficacy of Sorafenib against prostate cancer cells.

P Kharaziha et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.